Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum

Neurofilament light chain (NfL) is a potential diagnostic and prognostic plasma biomarker for numerous neurological diseases including Alzheimer’s disease (AD). In this study, we investigated the relationship between baseline plasma concentration of Nfl and Mild Cognitive Impairment in participants...

Full description

Bibliographic Details
Main Authors:	Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Constance Delaby, Olivier Hanon
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	International Journal of Molecular Sciences
Subjects:	Alzheimer’s disease neurofilament light chain blood cognitive decline
Online Access:	https://www.mdpi.com/1422-0067/24/24/17361

Similar Items

Neurofilaments contribution in clinic: state of the art
by: Constance Delaby, et al.
Published: (2022-11-01)

Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges
by: Salomé Coppens, et al.
Published: (2023-07-01)

Olfactory function, neurofilament light chain, and cognitive trajectory: A 12‐year follow‐up of the Shanghai Aging Study
by: Zhenxu Xiao, et al.
Published: (2023-10-01)

A neurologist’s perspective on serum neurofilament light in the memory clinic: a prospective implementation study
by: E. A. J. Willemse, et al.
Published: (2021-05-01)

Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy
by: Zhang Q, et al.
Published: (2023-01-01)

The diagnostic significance of neurofilament heavy chains in cerebrospinal fluid in amyotrophic lateral sclerosis
by: Anastasia V. Vladykina, et al.
Published: (2021-03-01)

Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
by: Ze-Hu Sheng, et al.
Published: (2022-12-01)

Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß1−42, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
by: Emmanuelle Duron, et al.
Published: (2019-02-01)

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ1–42 and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
by: Emmanuelle Duron, et al.
Published: (2018-10-01)

Functional Characterization of Neurofilament Light Splicing and Misbalance in Zebrafish
by: Doris Lou Demy, et al.
Published: (2020-05-01)

Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
by: Isabella Zanella, et al.
Published: (2022-05-01)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
by: Yumei Liu, et al.
Published: (2022-09-01)

Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis
by: Miriam Fedičová, et al.
Published: (2023-04-01)

Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia
by: Magnus Johnsson, et al.
Published: (2024-01-01)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
by: Simon Thebault, et al.
Published: (2020-11-01)

Assembly and turnover of neurofilaments in growing axonal neurites
by: Edward F. Boumil, et al.
Published: (2018-01-01)

Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis
by: Vlad Eugen Tiu, et al.
Published: (2022-10-01)

Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates
by: Chiara Gallingani, et al.
Published: (2024-03-01)

Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments
by: C.B. Tauil, et al.
Published: (2021-01-01)

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer’s Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration
by: Shreyasee Das, et al.
Published: (2022-06-01)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
by: Yuri Matteo Falzone, et al.
Published: (2021-01-01)

Neurofilament Levels in Dendritic Spines Associate with Synaptic Status
by: Clara-Marie Gürth, et al.
Published: (2023-03-01)

Neurofilaments and traumatic brain injury
by: Mariusz Kobek, et al.
Published: (2015-03-01)

Influence of a GSK3β phosphorylation site within the proximal C-terminus of Neurofilament-H on neurofilament dynamics
by: Rishel Brenna Vohnoutka, et al.
Published: (2017-10-01)

Circulating Neurofilament Light Predicts Cognitive Decline in Patients With Post-stroke Subjective Cognitive Impairment
by: Jian-Hong Wang, et al.
Published: (2021-05-01)

Neurofilament distribution in the superior labrum and the long head of the biceps tendon
by: Sandra Boesmueller, et al.
Published: (2017-11-01)

Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study
by: Karl Götze, et al.
Published: (2023-01-01)

Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults
by: Lingxiao He, et al.
Published: (2020-10-01)

Neurofilament Light Chain as A Biomarker for Brain Metastases
by: Anne Winther-Larsen, et al.
Published: (2020-10-01)

Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi
by: Marina Flotats-Bastardas, et al.
Published: (2023-12-01)

Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
by: Lin JB, et al.
Published: (2023-08-01)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
by: Piotr Lewczuk, et al.
Published: (2018-07-01)

Value of Neurofilament Light Chain as a Biomarker in Peripheral Neuropathy
by: SUN Xiaoling, HUANG Kaiwei, WAN Xinbei, WU Ying, LI Zhijun
Published: (2022-11-01)

Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
by: Hongge Wang, et al.
Published: (2022-03-01)

The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
by: Adriano D. S. Targa, et al.
Published: (2021-09-01)

Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer
by: Gwen Schroyen, et al.
Published: (2023-11-01)

Research progression of neurofilament light chain in the diagnosis and differential diagnosis of Parkinson's disease
by: YIN Wei⁃fang, et al.
Published: (2022-04-01)

Spectral exponent assessment and neurofilament light chain: a comprehensive approach to describe recovery patterns in stroke
by: Jacopo Lanzone, et al.
Published: (2024-03-01)

Neurofilament Light Chain: A Candidate Biomarker of Perioperative Stroke
by: Xiaoting Zhang, et al.
Published: (2022-07-01)

Shedding light on neurofilament involvement in cognitive decline in obstructive sleep apnea and its possible role as a biomarker
by: Julia Jaromirska, et al.
Published: (2023-11-01)